Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

BioLight to Distribute Laser Eye Surgery System in Hong Kong, Macao

BioPhotonics
Mar 2015
TEL AVIV, Israel — BioLight Life Sciences Investments Ltd. will distribute IOPtima’s IOPtiMate laser eye surgery system in Hong Kong and Macao, with a purchase commitment of at least nine systems.

IOPtiMate is based on CO2 laser technology and enables filtration surgery, which treats glaucoma without penetrating the inner part of the eyeball. Compared with alternatives, this allows substantial reductions in postoperative complications and use of eye drops, according to BioLight.

A leading medical center in Hong Kong recently purchased the system, while another is using IOPtiMate on a trial basis.

“Entering into a strategic distribution agreement in Hong Kong and Macao is an additional significant advancement in our plan to penetrate developing markets in Asia, where there is no available solution for a large population of patients,” said BioLight CEO Suzana Nahum-Zilberberg.

Earlier this year BioLight and IOPtima reached a distribution agreement for China with a purchase commitment of 100 systems.

For more information, visit www.bio-light.co.il.

GLOSSARY
ophthalmology
The branch of medicine involved in the study of the anatomy, functions, diseases and treatments of the eye.
BusinessAsia-PacificophthalmologylasersBiophotonicslaser eye surgeryCo2 lasersBioLight Life Sciences InvestmentsIOPtimaAsia-Pacific Special Sectionlight speedRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!